Literature DB >> 29762208

Prevalence of Atopic Dermatitis and Pattern of Drug Therapy in Malaysian Children.

Yi-Yeong Goh1, Fazlollah Keshavarzi, Yik Ling Chew.   

Abstract

BACKGROUND: Atopic dermatitis (AD) is a chronic relapsing, noncontagious skin inflammation characterized by dry skin and itch. Mutation in filaggrin gene leads to defective skin barrier, allowing entry of allergen and eliciting immunological response.
OBJECTIVES: The aims of this study were to investigate the prevalence of AD in Malaysian children and to understand the pattern of drug therapy. Such information could be useful to establish the relationship between ethnicity and family history of atopy and the development of associated signs and symptoms.
METHODS: A cross-sectional survey was conducted among children attending kindergartens and nurseries. Standardized questionnaires were filled out by parents.
RESULTS: Overall prevalence of AD was 13.4%. Of 384 participants recruited, the highest prevalence was observed in males, Malays, participants younger than 2 years, and those with atopic background such as asthma, hay fever, and family history of atopic diseases. Calamine and white soft paraffin were the preferred choice of nonprescription drugs, whereas topical hydrocortisone seemed to be the preferred choice of prescription drug in the management of AD.
CONCLUSIONS: The overall prevalence is comparable to that reported in the International Study of Asthma and Allergies in Childhood Phase One. There is an association between ethnicity and AD prevalence. Topical corticosteroids and emollients are the mainstay of AD management among Malaysians.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29762208     DOI: 10.1097/DER.0000000000000376

Source DB:  PubMed          Journal:  Dermatitis        ISSN: 1710-3568            Impact factor:   4.845


  6 in total

1.  Practical Recommendations for the Topical Treatment of Atopic Dermatitis in South and East Asia.

Authors:  David Luk; Kam Lun Ellis Hon; Maria Victoria C Dizon; Kin-Fon Leong; Yong-Kwang Tay; Mark Jean-Aan Koh; Nisha Suyien Chandran; Siriwan Wananukul; Susheera Chatproedprai; Thomas Luger
Journal:  Dermatol Ther (Heidelb)       Date:  2020-12-12

2.  Effectiveness of Cimetidine as Adjuvant Therapy in the Treatment of Acute-Extrinsic Atopic Dermatitis: A Double-Blind Randomized Controlled Trial.

Authors:  Endi Novianto; Tjut N A Jacoeb; Wresti Indriatmi; Rianto Setiabudy; Rahajuningsih D Setiabudy; Murdani Abdullah; Iris Rengganis; Oki Suwarsa; Retno W Soebaryo
Journal:  Dermatol Ther (Heidelb)       Date:  2022-02-17

Review 3.  Cassia alata, Coriandrum sativum, Curcuma longa and Azadirachta indica: Food Ingredients as Complementary and Alternative Therapies for Atopic Dermatitis-A Comprehensive Review.

Authors:  Yik-Ling Chew; Mei-Ann Khor; Zhao Xu; Sue-Kei Lee; Jing-Wen Keng; Sze-Huey Sang; Gabriel Akyirem Akowuah; Khang Wen Goh; Kai Bin Liew; Long Chiau Ming
Journal:  Molecules       Date:  2022-08-26       Impact factor: 4.927

4.  Risk factors for current wheeze among school children (6-7 and 13-14 years old) in Khuzestan, Iran.

Authors:  Maryam Dastoorpoor; Narges Khodadadi; Farzan Madadizadeh; Elham Shahidizadeh; Maryam Haddadzadeh Shoushtari; Hanieh Raji; Esmaeil Idani
Journal:  Public Health Pract (Oxf)       Date:  2021-07-30

5.  Assessing the prevalence and severity of asthma, rhinitis, and eczema among schoolchildren (6-7 and 13-14 years old) in Khuzestan, Iran: a cross-sectional survey.

Authors:  Maryam Dastoorpoor; Narges Khodadadi; Farzan Madadizadeh; Hanieh Raji; Elham Shahidizadeh; Esmaeil Idani; Maryam Haddadzadeh Shoushtari
Journal:  BMC Pediatr       Date:  2022-08-02       Impact factor: 2.567

Review 6.  Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review.

Authors:  Yuri I Lopez Carrera; Anwar Al Hammadi; Yu-Huei Huang; Lyndon J Llamado; Ehab Mahgoub; Anna M Tallman
Journal:  Dermatol Ther (Heidelb)       Date:  2019-10-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.